Brent Saunders

Chief Executive Officer, President and Chairman of Vesper Healthcare Acquisition Corp.

Brent Saunders has over 25 years of experience in various aspects of healthcare and has been in leadership roles at several prominent global pharmaceutical and healthcare companies. He currently serves as chief executive officer, president and chairman of Vesper Healthcare Acquisition Corp., a special purpose acquisition corporation. Until its acquisition by AbbVie in May 2020, Mr. Saunders served as chairman, president and chief executive officer of Allergan plc. Prior to this, Mr. Saunders served as chief executive officer of Forest Laboratories Inc., a role he held until the company’s merger with Actavis in 2014. Following the merger with Actavis, Mr. Saunders was named chief executive officer of the combined business in 2015. From March 2010 until August 2013, Mr. Saunders served as chief executive officer of Bausch + Lomb Incorporated until its acquisition by Valeant in 2013.

Mr. Saunders holds a B.A. degree from the University of Pittsburgh, a J.D. degree from the Temple University School of Law, and an MBA from the Temple University School of Business.

Mr. Saunders serves as chair of the board of directors for OcuTerra Therapeutics, Inc. a clinical stage ophthalmology drug development company, and as a director of Cisco Systems, Inc., a global telecommunications company, and BridgeBio Pharma Inc., a bio pharmaceutical company. He is also a member of The Business Council.